Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chiappetta

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 8, 2007
Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugsDiego A Chiappetta, Alejandro Sosnik
Current HIV Research|February 18, 2010
A highly concentrated and taste-improved aqueous formulation of efavirenz for a more appropriate pediatric management of the anti-HIV therapyDiego A Chiappetta, Christian Hocht, Alejandro Sosnik
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2009
Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing aheadAlejandro Sosnik, Diego A Chiappetta, Angel M Carcaboso
Colloids and Surfaces. B, Biointerfaces|September 27, 2012
Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenzKatia P Seremeta, Diego A Chiappetta, Alejandro Sosnik
Journal of the Royal Society, Interface|August 26, 2011
Cryoprotection-lyophilization and physical stabilization of rifampicin-loaded flower-like polymeric micellesMarcela A Moretton, Diego A Chiappetta, Alejandro Sosnik
Nanomedicine (London, England)|December 23, 2009
Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected]Diego A Chiappetta, Christian Hocht, Carlos Taira, et al.
Biomacromolecules|November 20, 2012
Micro/nanostructured hyaluronic acid matrices with tuned swelling and drug release propertiesYanina Minaberry, Diego A Chiappetta, Alejandro Sosnik, et al.
Biomaterials|December 28, 2010
Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micellesDiego A Chiappetta, Christian Hocht, Carlos Taira, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 25, 2013
Extemporaneous clobazam suspensions for paediatric use prepared from commercially available tablets and pure drugF Buontempo, M A Moretton, E Quiroga, et al.
Colloids and Surfaces. B, Biointerfaces|July 15, 2010
Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micellesMarcela A Moretton, Romina J Glisoni, Diego A Chiappetta, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 8, 2007
Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugsDiego A Chiappetta, Alejandro Sosnik
Current HIV Research|February 18, 2010
A highly concentrated and taste-improved aqueous formulation of efavirenz for a more appropriate pediatric management of the anti-HIV therapyDiego A Chiappetta, Christian Hocht, Alejandro Sosnik
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2009
Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing aheadAlejandro Sosnik, Diego A Chiappetta, Angel M Carcaboso
Colloids and Surfaces. B, Biointerfaces|September 27, 2012
Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenzKatia P Seremeta, Diego A Chiappetta, Alejandro Sosnik
Journal of the Royal Society, Interface|August 26, 2011
Cryoprotection-lyophilization and physical stabilization of rifampicin-loaded flower-like polymeric micellesMarcela A Moretton, Diego A Chiappetta, Alejandro Sosnik
Nanomedicine (London, England)|December 23, 2009
Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected]Diego A Chiappetta, Christian Hocht, Carlos Taira, et al.
Biomacromolecules|November 20, 2012
Micro/nanostructured hyaluronic acid matrices with tuned swelling and drug release propertiesYanina Minaberry, Diego A Chiappetta, Alejandro Sosnik, et al.
Biomaterials|December 28, 2010
Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micellesDiego A Chiappetta, Christian Hocht, Carlos Taira, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 25, 2013
Extemporaneous clobazam suspensions for paediatric use prepared from commercially available tablets and pure drugF Buontempo, M A Moretton, E Quiroga, et al.
Colloids and Surfaces. B, Biointerfaces|July 15, 2010
Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micellesMarcela A Moretton, Romina J Glisoni, Diego A Chiappetta, et al.
Pageof 8